Literature DB >> 1002396

Magnesium deficiency in children with urolithiasis.

V Revúsová, J Gratzlová, V Zvara, J Krídl.   

Abstract

In a group of 57 children with urolithiasis hypomagnesaemia was found in 15 cases (26.3%). All children but one with abnormally low serum magnesium levels had recurrent or bilateral nephrolithiasis or nephrocalcinosis. Prevalence of hyperoxaluria and hypercalciuria, marked severity of the clinical features, abnormality of Ca metabolism and its responsiveness to MgO treatment were demonstrable in Mg deficiency.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1002396     DOI: 10.1007/bf02082240

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi.

Authors:  E L Prien; S F Gershoff
Journal:  J Urol       Date:  1974-10       Impact factor: 7.450

2.  Acute induction of soft tissue calcification with transient hyperphosphatemia in the KK mouse by modification in dietary contents of calcium, phosphorus, and magnesium.

Authors:  Y Hamuro; A Shino; Z Suzuoki
Journal:  J Nutr       Date:  1970-04       Impact factor: 4.798

3.  Effect of dietary magnesium on the development of nephrocalcinosis in rats.

Authors:  A Goulding; R S Malthus
Journal:  J Nutr       Date:  1969-03       Impact factor: 4.798

4.  The effects of magnesium and pH on experimental calcium oxalate stone disease.

Authors:  T A Borden; E S Lyon
Journal:  Invest Urol       Date:  1969-01

5.  Interrelationships of thyroxine, citrate, and renal calcificiation in the magnesium-deficient rat.

Authors:  P G Reeves; R M Forbes
Journal:  Proc Soc Exp Biol Med       Date:  1971-07

6.  Oral magnesium intake and its effect on various urinary constituents in the prophylaxis of urolithiasis.

Authors:  F P Kohler; C A Uhle
Journal:  J Urol       Date:  1966-11       Impact factor: 7.450

  6 in total
  4 in total

1.  Blood lymphocyte magnesium in kidney stone formers.

Authors:  V Revúsová; D Pekníková; D Polakovicová; J Breza
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

2.  Development of metaphylaxis in calcium urolithiasis: a restriction of conventional drug therapy.

Authors:  R Kocvara; G Louzenský; J Tuíková
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

3.  Impaired renal tubular reabsorption of magnesium (TRMg) in Ca-containing kidney stone formers.

Authors:  V Revúsová; J Gratzlová; V Zvara
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

4.  Chronic renal insufficiency (CRI) in urolithiasis.

Authors:  V Revúsová; Z Zvara; J Krídl; E Borosová; V Pribylincová; J Reznicek; J Gratzlová
Journal:  Int Urol Nephrol       Date:  1980       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.